Skip to content

Evaluation of Treatment With Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile Men With Idiopathic Oligoasthenoteratospermia

Evaluation of Treatment With Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile Men With Idiopathic Oligoasthenoteratospermia a Placebo Controlled Clinical Trial

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06342856
Acronym
infertility
Enrollment
120
Registered
2024-04-02
Start date
2023-06-15
Completion date
2024-07-01
Last updated
2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility Unexplained, Oligospermia

Keywords

infertility, oligospermia, coenzyme Q1o

Brief summary

Evaluation of treatment with Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile men with Idiopathic Oligoasthenoteratospermia

Detailed description

Evaluation of treatment with Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile men with Idiopathic Oligoasthenoteratospermia a placebo controlled clinical trial

Interventions

DRUGco enzyme Q10 , L- Carnitine

Patient fulfilling inclusion criteria after obtaining consent will be randomized into four equal groups randomization will be computer based

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

* of in¬fertility of 1 year or more without the use of contraception

Exclusion criteria

* o Active genital infections. * Patients with ejaculatory dysfunction * Azoospermia

Design outcomes

Primary

MeasureTime frameDescription
Changes in Semen analysis parameters compared to baseline6 monthsChanges in Semen analysis parameters compared to baseline

Secondary

MeasureTime frameDescription
Serum hormone levels ([FSH], [LH], testosterone, and prolactin) levels compared to baseline and Cost analysis6 mothsSerum hormone levels (\[FSH\], \[LH\], testosterone, and prolactin) levels compared to baseline and Cost analysis

Countries

Egypt

Contacts

Primary Contactwaleed,mo abdelhamid, ass lecturer
drwaleedabdelhamid@gmail.com01013340534

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026